Retraction

Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL

Paper Information

Record ID:
19274
Publication Date:
May 23, 2016
Retraction Date:
October 01, 2018 (7.1 years years ago)
Article Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (17)

17
Total Citations
6
Post-Retraction
(35.3%)
8
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
2 After 2+ years
1739 Days since retraction (latest)
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Unknown
Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
Joanna Kempska, Leticia Oliveira‐Ferrer, Astrid Grottke et al. (17 authors)
Frontiers in Oncology Open Access
Published: Jul 2023
6 citations
1739 days after retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Apr 2023
1649 days after retraction
MicroRNA-892a regulates laryngocarcinoma cell proliferation via Dicer
Jinhui Dong, Jianxin Wang, Chunguang Shan et al. (5 authors)
Experimental Biology and Medicine Open Access
Published: Jun 2020
7 citations
622 days after retraction
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression
Lorena Quirico, Francesca Orso, Carla Lucia Esposito et al. (10 authors)
International Journal of Biological Sciences Open Access
Published: Jan 2020
24 citations
457 days after retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Jul 2019
283 days after retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Nov 2018
31 days after retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Oct 2018
Same day as retraction
Does Axl have potential as a therapeutic target in pancreatic cancer?
Wenting Du, Rolf A. Brekken
Expert Opinion on Therapeutic Targets Open Access
Published: Sep 2018
28 citations
7 days before retraction
Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
Keisuke Iida, Ryo Sakai, Shota Yokoyama et al. (9 authors)
Scientific Reports Open Access
Published: Dec 2017
23 citations
292 days before retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Jul 2017
450 days before retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: May 2017
494 days before retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Mar 2017
579 days before retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Feb 2017
588 days before retraction
Paper citing Dicer Elicits Paclitaxel Chemosensitization and Su...
Unknown Authors
Unknown Journal
Published: Aug 2016
761 days before retraction
Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention
Bernhard Biersack
Non-coding RNA Research Open Access
Published: Jul 2016
47 citations
795 days before retraction
Quick Stats
Total Citations: 17
Years Since Retraction: 7.1 years
Open Access: Yes
Last Checked: Never